Author Question: A woman would likely be advised to switch from a progestin-only hormonal contraceptive to a ... (Read 24 times)

joesmith1212

  • Hero Member
  • *****
  • Posts: 549
A woman would likely be advised to switch from a progestin-only hormonal contraceptive to a combination hormonal contraceptive due to _____.
 a. weight gain
 b. irritability
 c. fatigue
 d. headache
 e. abdominal pain

Question 2

An essential amino acid:
 
 a. is not necessary to the diet.
  b. must be supplied by the diet.
  c. can be made from glucose in the body.
  d. can be made from fat in the body.



janeli1

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

a

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

joesmith1212

  • Hero Member
  • *****
  • Posts: 549
Both answers were spot on, thank you once again



janeli1

  • Sr. Member
  • ****
  • Posts: 330

 

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Historic treatments for rheumatoid arthritis have included gold salts, acupuncture, a diet consisting of apples or rhubarb, nutmeg, nettles, bee venom, bracelets made of copper, prayer, rest, tooth extractions, fasting, honey, vitamins, insulin, snow collected on Christmas, magnets, and electric convulsion therapy.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library